These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29483388)

  • 1. Tongxinluo Improves Apolipoprotein E-Deficient Mouse Heart Function.
    Yuan GQ; Gao S; Geng YJ; Tang YP; Zheng MJ; Shelat HS; Collins S; Wu HJ; Wu YL
    Chin Med J (Engl); 2018 Mar; 131(5):544-552. PubMed ID: 29483388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.
    Wang B; Yang Q; Bai WW; Xing YF; Lu XT; Sun YY; Zhao YX
    PLoS One; 2014; 9(6):e98047. PubMed ID: 24887083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese medicine Tongxinluo reduces atherosclerotic lesion by attenuating oxidative stress and inflammation in microvascular endothelial cells.
    Wu XL; Zheng B; Jin LS; Zhang RN; He M; Yang Z; Wen JK
    Int J Clin Exp Pathol; 2015; 8(6):6323-33. PubMed ID: 26261508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip.
    Ma J; Qiao L; Meng L; Ma L; Zhao Y; Liu X; Ni M; Zhang Y
    Biomed Pharmacother; 2019 May; 113():108767. PubMed ID: 30870720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese medicine Tongxinluo increases tight junction protein levels by inducing KLF5 expression in microvascular endothelial cells.
    Li LM; Zheng B; Zhang RN; Jin LS; Zheng CY; Wang C; Zhou PP; Guo ZW; Ma D; Wen JK
    Cell Biochem Funct; 2015 Jun; 33(4):226-34. PubMed ID: 25907265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tongxinluo Activates PI3K/AKT Signaling Pathway to Inhibit Endothelial Mesenchymal Transition and Attenuate Myocardial Fibrosis after Ischemia-Reperfusion in Mice.
    Wei YR; Hou YL; Yin YJ; Li Z; Liu Y; Han NX; Wang ZX; Liu L; Wang XQ; Hao YJ; Ma K; Gu JJ; Jia ZH
    Chin J Integr Med; 2024 Jul; 30(7):608-615. PubMed ID: 38386252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
    Zhang L; Liu Y; Lu XT; Wu YL; Zhang C; Ji XP; Wang R; Liu CX; Feng JB; Jiang H; Xu XS; Zhao YX; Zhang Y
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2004-14. PubMed ID: 19801495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tongxinluo on the neointima formation and expression of inflammatory cytokines in rats after carotid artery balloon injury.
    Yao EH; Wang HJ; Xu CS
    Indian J Pharmacol; 2014; 46(5):510-4. PubMed ID: 25298580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction.
    Wang Y; Kuang X; Yin Y; Han N; Chang L; Wang H; Hou Y; Li H; Li Z; Liu Y; Hao Y; Wei Y; Wang X; Jia Z
    Biomed Pharmacother; 2022 Jan; 145():112367. PubMed ID: 34740097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect and mechanism of recombinant hirudin on atherosclerotic plaques in apolipoprotein E knockout (ApoE(-/-)) mice].
    Tian JF; Ge CJ; Lu SZ; Yuan F; Zhao K
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Feb; 35(2):198-203. PubMed ID: 25881466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis].
    Mao MJ; Hu JP; Chen FR; Zhang YY; Liu P
    Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):306-12. PubMed ID: 21419084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptor-α deletion decreases heart function and exercise performance in apolipoprotein E-deficient mice.
    Liu KL; Canaple L; Del Carmine P; Gauthier K; Beylot M; Lo M
    Physiol Genomics; 2016 Feb; 48(2):73-81. PubMed ID: 26672044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development.
    Pan S; White TA; Witt TA; Chiriac A; Mueske CS; Simari RD
    Circ Res; 2009 Sep; 105(7):713-20, 8 p following 720. PubMed ID: 19713537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
    Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y
    Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition.
    Yin Y; Zhang Q; Zhao Q; Ding G; Wei C; Chang L; Li H; Bei H; Wang H; Liang J; Jia Z
    Biomed Res Int; 2019; 2019():6595437. PubMed ID: 31317035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of tongxinluo on endothelin-1 in the mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jin Z; Wu Y; Yang W; Chen J; Gao R; Chen Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Oct; 25(10):902-6. PubMed ID: 16313114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention of Tongxinluo capsule against vascular lesion of atherosclerosis and its effect on lectin-like oxidized low density lipoprotein receptor-1 expression in rabbits.
    Yu YH; Xu XQ; Wang Y; Sun SZ; Chen Y
    Chin J Integr Med; 2006 Mar; 12(1):32-6. PubMed ID: 16571281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.